SCHEMBL16720971

SCHEMBL16720971

Cc1nc([C]=O)ccc1Br

nearest known ligand 0.36

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.36
NPC1 O15118 8/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.34
LMNA P02545 1/20 0.34
KMT2A Q03164 2/20 0.33
HSD17B10 Q99714 1/20 0.33
MAPT P10636 2/20 0.31
KDM4E B2RXH2 1/20 0.31
EDNRA P25101 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL149575 0.78 EGLN2 (0.39) RAB9ANPC1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL19728911 0.72 GRM5 (0.32) RAB9ANPC1KMT2A
SCHEMBL21807767 0.71 GRM5 (0.33) RAB9ANPC1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL156190 0.69
SCHEMBL31452225 0.69
SCHEMBL578026 0.69
Hydrochloric Acid SCHEMBL6604967 0.67 RAB9A (0.42) RAB9ANPC1ALDH1A1MAPK1SMN1; SMN2
SCHEMBL502824 0.65
SCHEMBL4609092 0.65
SCHEMBL2493536 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3068768-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS Merck Sharp & Dohme Corp. (US) 2016-09-21 EP disclosed
WO-2015073342-A1 ANTIDIABETIC TRICYCLIC COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2015-05-21 WO disclosed